- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02599103
The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects
November 5, 2015 updated by: Wen-Harn Pan, Academia Sinica, Taiwan
Fats and oils play important roles in maintaining human nutrition and health through providing energy, essential fatty acids, and acting as modulators of many biological processes (signal transduction, immunity and inflammation).
Due to differences in the fatty acid composition and content of antioxidants of individual cooking oils, the degree of oxidative and thermolytic reactions may vary oil by oil.
It is lack of human feeding study to investigate the molecular mechanisms on how and which deep-fried oil exerts its adverse effects.
The investigators are also lack of biomarkers for monitoring deep-fried oil exposure.
Therefore, the purpose of this study is to compare how human body responds differently to several popular uncooked and deep-fried oils with varied fatty acid compositions with respect of oxylipin profile, inflammatory markers, non-targeted metabolomics, and transcriptomics.
The investigators will recruit 20 volunteers, provided them once a week the milk shakes prepared from 60g of olive oil, soybean oil, palm oil, camellia oil, tallow (butter), and deep-fried oils of the last 4, respectively; in comparison with a no-fat milk shake control.
The experiments lasted for 10 weeks.。Each
time; serum, plasma, whole blood and urine samples were collected at baseline, after 2 hours, and after 4 hours.
The investigators anticipate to find biomarker(s) for deep-frying, and contribute to the understanding of molecular mechanisms on how deep-fried oils exert adverse effects toward health through integrative omics or so-called system biology approaches.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Non-smoking, non-drinker, usual dietary intake
- BMI : 18.5~27 kg/m2
Exclusion Criteria:
- Over the past two weeks have suffered from acute illness.
- None of the subjects was taking any supplemental vitamins, antioxidants or medication at that time.
- Taking steroids or non-steroidal anti-inflammatory drug, such as Aspirin or Panadol in the past one week.
- Cancer or other severe diseases was diagnosed.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: fat-free milkshake
|
participants drinks a fat-free milk shakes
|
Active Comparator: Olive oil
|
participants drinks the milk shakes prepared from 60g of olive oil
|
Experimental: soybean oil
|
participants drinks the milk shakes prepared from 60g of soybean oil
|
Experimental: fried soybean oil
|
participants drinks the milk shakes prepared from 60g of fried soybean oil
|
Experimental: palm oil
|
participants drinks the milk shakes prepared from 60g of palm oil
|
Experimental: fried palm oil
|
participants drinks the milk shakes prepared from 60g of fried palm oil
|
Experimental: camellia oil
|
participants drinks the milk shakes prepared from 60g of camellia oil
|
Experimental: fried camellia oil
|
participants drinks the milk shakes prepared from 60g of fried camellia oil
|
Experimental: tallow
|
participants drinks the milk shakes prepared from 60g of tallow
|
Experimental: fried tallow
|
participants drinks the milk shakes prepared from 60g of fried tallow
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The changs of metabolomics profile between before and after oil consumption
Time Frame: baseline to 2 hours and 4 hours after oil consumption
|
This is a metabolomics study.
We measured retention time (min), mass and abundance of serum metabolites with LC-QTOF at 3 time points.
Then, we compared the abundance of metabolites between different oil consumption time ( before and after ) and assessed the health effects of cooking oils.
|
baseline to 2 hours and 4 hours after oil consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
September 15, 2015
First Submitted That Met QC Criteria
November 5, 2015
First Posted (Estimate)
November 6, 2015
Study Record Updates
Last Update Posted (Estimate)
November 6, 2015
Last Update Submitted That Met QC Criteria
November 5, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AS-IRB02-102083
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Neoplasms
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
NuCana plcCompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States, France, United Kingdom
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...Active, not recruitingColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
The Queen Elizabeth HospitalNovartis; AmgenCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalAustralia
-
Novartis PharmaceuticalsCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
ProgenaBiomeRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Cancer Metastatic | Colorectal Carcinoma | Colorectal Adenocarcinoma | Colorectal SarcomaUnited States
-
Pawel KalinskiNational Cancer Institute (NCI)CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
Jeremy MeyerUniversity Hospital, Geneva; Hôpital Fribourgeois; Spital Biel, SwitzerlandNot yet recruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Adenocarcinoma | Colorectal Polyp | Colorectal Neoplasms Malignant | Colorectal Neoplasms, Benign
-
Bristol-Myers SquibbNovartisActive, not recruitingColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaItaly, United States, Canada, Spain, Argentina, Australia, Belgium, Chile, Czechia, Germany
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Disorders | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Polyp | Colorectal Neoplasms Malignant | Colorectal Adenomatous Polyp | Colorectal Cancer Stage I | Colorectal Adenoma... and other conditionsUnited States, Italy, China, Spain, Japan
Clinical Trials on Fat-free milkshake
-
University of AberdeenUniversity of DundeeUnknown
-
Maastricht University Medical CenterCompletedVascular Function | Carbohydrates | Postprandial Metabolism | Proteins | Dietary Fats | MacronutrientsNetherlands
-
Nantes University HospitalNot yet recruitingNeurogenic Thoracic Outlet Syndrome
-
Ryerson UniversityNational Dairy Council; Dairy Management Inc.Recruiting
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingIdiopathic Pulmonary FibrosisChina
-
Ain Shams UniversityCompletedGingival RecessionEgypt
-
University of ReadingMinistry of National Education, TurkeyRecruitingPhysical Activity | Gastric Emptying | Appetitive Behavior | Energy IntakeUnited Kingdom
-
University of Nebraska LincolnNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Wayne... and other collaboratorsEnrolling by invitation
-
Ohio State UniversityCompletedMetabolic Syndrome | Non-alcoholic Fatty LiverUnited States